GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: CNTO-1275 | L04AC05 | Stelara® | TT-20
                                 ustekinumab is an approved drug (FDA (2009), EMA (2009)) Compound class: 
                                                            Antibody
                                 
                                    
                                        Comment: Ustekinumab suppresses the immunomodulatory actions of both IL-12 and IL-23 on T-cell sub-populations. It binds to the common p40 subunit (IL12B) shared by these cytokines.  Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Biosimilars: 
 *After expiry of the period of exclusivity for the first interchangeable biosimilar product. | 
| Classification  | |
| Compound class | Antibody | 
| Approved drug? | Yes. EU EMA (2009) | US FDA (2009) | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 8954 | ustekinumab | 
| Synonyms  | 
| CNTO-1275 | L04AC05 | Stelara® | TT-20 | 
| Database Links  | |
| Specialist databases | |
| IMGT/mAb-DB | 172 | 
| Other databases | |
| GtoPdb PubChem SID | 178103467 | 
| PubChem SID | 178103467 | 
| Search PubMed clinical trials | ustekinumab | 
| Search PubMed titles | ustekinumab | 
| Search PubMed titles/abstracts | ustekinumab | 
| Wikipedia | Ustekinumab |